Xtacy Therapeutics (TSE:XTCY) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Xtacy Therapeutics Corp. has announced changes to its Board of Directors, with Vanni Barbon joining as a Director and the new Audit Chair, bringing a wealth of experience in banking and public markets. The company expressed gratitude to Ashleigh Vogstad for her service as she steps down, and CEO Meris Kott anticipates continued advice from her. Xtacy Therapeutics focuses on wellness consumer products, including psychedelics and healthcare-related targets.
For further insights into TSE:XTCY stock, check out TipRanks’ Stock Analysis page.
